Month: January 2021

Categories
Entertainment

Hearken to Sabrina Carpenter’s “Pores and skin”

Listen to Sabrina Carpenter's "Skin"

Sabrina Carpenter is starting the year blessing her fans with a new single and damn it, we’re excited. The Work it The actress teased the release of her latest single, “Skin”, a few hours before it came out at midnight on January 22nd, with nothing but the time of waste in her caption. We love an artist who knows how to keep us on our toes with anticipation!

The song has that sultry tone we’ve heard from Carpenter before, especially on their recent EPs Singular: act 1 and Singular: Act II. But instead of longing for love like in “Almost Love” or enjoying the attention of her admirers in “Looking at Me”, the singer raves about the fact that someone gets under her skin. “You can try / get under my skin / while he’s on mine,” she sings in the emotional melody.

The singer has been telling fans that she has big news for her in the New Year and if this new single isn’t, we could be looking for another musical project! We are definitely ready for more of her music, so keep your fingers crossed that more is coming in 2021! Hear “skin” above.

Categories
Business

Russia’s Sputnik vaccine will get its first approval within the EU, UAE

Russia’s Sputnik vaccine gets its first approval in the EU, UAE

A medical worker fills a syringe with the Gam-COVID-Vac vaccine (under the brand name Sputnik V) in Butovo, in southern Moscow.

Sergei Savostyanov | TASS | Getty Images

DUBAI, United Arab Emirates – Russian vaccine Sputnik V Covid-19 saw a number of improvements on Thursday as Hungary and the United Arab Emirates became the first countries in the European Union and the Gulf region to register the emergency shot.

Hungary’s decision was confirmed by President Viktor Orban’s spokesman, who said that if the country agrees to a shipping agreement with Moscow, it will be the first EU country to receive the vaccine. This is because the country’s cases have fallen from a high of more than 6,000 a day in early December to below 2,000 a day.

“This decision is very important as it shows that over 90% of the vaccine’s safety and efficacy is valued by our partners in Hungary,” said Kirill Dmitriev, head of the Russian Direct Investment Fund, in a statement.

The EU drug regulator has not yet approved the Russian stab, although Chancellor Angela Merkel gave Sputnik further hope on Thursday, suggesting that the German vaccine regulator could advise Russia on steering the EU approval process. The RDIF has submitted Sputnik for EU registration and expects its review in February.

UAE approval comes amid a dramatic surge in infections

The UAE approval comes amid a record spike in cases in the little Gulf Sheikh, which excelled internationally by welcoming tourists and fully reopening its economy by late summer last year.

Confirmed coronavirus cases have more than tripled in about three weeks, prompting Emirati authorities to suspend unnecessary hospital surgery and “entertainment” activities in their busy hotels and restaurants just days after the country gave assurances that the virus was under Control was to fail.

The UAE’s daily number of cases hit a record high of 3,529 on Thursday, well above neighboring Gulf states, where registered infections are below 500 per day.

A man from the Emirates wearing a protective mask walks at al-Barsha Health Center in the Gulf of Dubai on December 24, 2020.

GIUSEPPE CACACE | AFP via Getty Images

Sputnik V will be the third vaccine to be used in the United Arab Emirates after China’s Sinopharm vaccine and the Pfizer BioNTech vaccine developed in the US and Germany were released to the public in December. The country of around 10 million people is running the second fastest national vaccination campaign in the world after Israel per capita, according to the government, and aims to vaccinate half of the country’s population by the end of March.

“The decision is part of the UAE’s comprehensive and integrated efforts to ensure a higher level of prevention,” the country’s health ministry said in a statement on Thursday about Sputnik’s approval. “The study results have demonstrated the vaccine’s effectiveness in eliciting a strong antibody response to the virus, its safety to use and its compliance with international safety and efficacy standards.”

Lack of late-stage experimental data

The approvals came despite detailed research data not yet published on the results of the phase 3 human vaccine study. The capital of the United Arab Emirates, Abu Dhabi, began phase 3 testing for Sputnik V earlier this month but has not released any data on it. 1,000 volunteers in the emirate have received their first dose, according to RDIF.

Sputnik V, which according to its developer, the Gamaleya Research Institute, is 91% effective after two doses, has been used across Russia for months. Scientists expressed concern about what many have described as the rush to launch the vaccine, which gave the green light for mass use in Russia ahead of the completion of Phase 3 trials.

As the first step in the largest vaccination campaign in Argentina’s history, first line health workers are receiving the Russian Sputnik V vaccine against the coronavirus.

Patricio Murphy | SOPA pictures | LightRocket | Getty Images

Analysis of the phase 1 and phase 2 studies of the vaccine was published in The Lancet in September, which found that the initial results did not show any significant negative side effects, but further studies were required.

“The results of the Phase III clinical trials are expected to be published shortly,” according to the official Sputnik V.

Prior to Thursday’s announcements, it had been approved for emergencies in nine countries and territories outside Russia – Algeria, Argentina, Bolivia, Belarus, Serbia, Venezuela, Paraguay, Turkmenistan and the Palestinian Territories.

Categories
Health

I took ‘no pleasure’ in contradicting Trump on Covid

I took 'no pleasure' in contradicting Trump on Covid

White House Health Advisor Dr. Anthony Fauci said he had “had no pleasure” in contradicting former President Donald Trump on the Covid-19 pandemic and felt more liberated to be able to discuss science without facing the new administration.

“The idea that you can get up here and talk about what you know, what evidence, what the science is and what it is – let the science do the talking. It’s a liberating feeling,” Fauci said on Thursday at his first press conference in the White House for months.

Fauci, now advising President Joe Biden, said he took no pleasure in contradicting Trump, who often made false claims about the severity of the pandemic as well as drugs designed to fight it.

“It was very clear that there were things that were being said, be it about things like hydroxychloroquine and other things that were really [were] It’s uncomfortable because they’re not based on scientific facts, “said Fauci.” I can tell you, I take absolutely no pleasure in contradicting the president, so it really was something you didn’t think you could actually say something and it wouldn’t be affected. “

He said it was “a liberating feeling” to talk about science and “that’s it”.

During the pandemic, Trump repeatedly criticized the government’s top coronavirus advisor, and even suggested firing him. Meanwhile, Fauci has questioned a number of Trump’s comments, including his repeated claims that the US fight against the virus “is turning around” when tens of thousands of people were actually infected every day.

Fauci didn’t attack his former boss as subtly when asked how the pandemic might have developed differently if a team like Biden’s had been deployed from the start. “One of the things we’re going to do is be completely transparent, open and honest,” said Fauci. “When something goes wrong, don’t point your fingers, but correct it and make everything we do based on science and evidence.”

Fauci said he discussed these exact priorities with Biden about 15 minutes before entering the meeting room.

In contrast, Trump had consistently downplayed the threat posed by the virus. He regularly denied any criticism of his administration’s approach to the pandemic, claiming that the US, which has the highest Covid death toll of any country in the world, responded to the virus better than almost any other nation. While Fauci and Trump’s coronavirus task force held daily briefings at the start of the outbreak, those regular updates were eventually dropped after Trump asked scientists if they could inject disinfectant or light into the body to kill the virus.

Thursday’s press conference came after Fauci told the World Health Organization earlier in the day that the U.S. would remain a member of the international agency under Biden. In May, Trump announced that the US would leave the WHO, but the process shouldn’t be completed until July.

Fauci said the Biden administration plans to work with the other 193 member states to “strengthen and reform” the United Nations health agency.

Categories
Politics

Right here’s What’s in Biden’s Government Orders Geared toward Covid-19

Here’s What’s in Biden’s Executive Orders Aimed at Covid-19

WASHINGTON – President Joseph R. Biden Jr. published a series of new presidential ordinances and guidelines on Thursday aimed at expediting the production of Covid-19 consumables, increasing testing capacity, and requiring masks to be worn during interstate travel – part of a He announced the extensive 200-page edition of the National Pandemic Strategy at an event in the White House.

Taken together, the orders signal Mr Biden’s earliest priorities to achieve a more central federal response to the spread of the coronavirus. Some of them reflect actions taken during the Trump administration, while most are trying to change course.

Here is the goal of the orders.

A mandate calls on those in charge of the authorities to look for bottlenecks in areas such as personal protective equipment and vaccine supply and to determine where the administration could apply the Defense Production Act to increase production. The White House has announced that it will use the Korean War-era law that the Trump administration used in its vaccine development program to increase production of a type of syringe that pharmacists can use to extract an extra dose from vaccine bottles.

The Biden team said they identified 12 “immediate supply shortages” critical to the pandemic response, including N95 surgical masks and isolation gowns, and swabs, reagents and pipettes used for testing.

“On the asymptomatic screening side, we are completely undercapacitive, so we need the money to really move the testing forward, which is so important for schools and businesses to reopen,” said Jeffrey D. Zients, the white’s new Covid-19 House response coordinator.

Another assignment is to set up a Pandemic Testing Board, an idea that came from President Franklin D. Roosevelt’s War Production Board, to speed up testing. The new government promises to expand the country’s range of rapid tests and double tests, and expand the laboratory space for testing and monitoring for coronavirus hotspots.

“These efforts will ensure we test where it is needed and where it is most needed, helping schools and businesses reopen safely and protect the most vulnerable, such as those living in long-term care facilities.” said Biden in his Thursday remarks.

Mr. Biden has vowed to use his powers as President to influence the wearing of masks wherever legally entitled, including on federal property and when traveling across state lines. An order issued on Thursday requires masks to be worn at airports and on many planes, intercity buses and trains.

The same ordinance also requires international travelers to demonstrate that they recently had a negative coronavirus test before traveling to the U.S. and adhere to the Centers for Disease Control and Prevention Quarantine guidelines after landing.

On a mandate, the Secretary for Health and Human Services and the White House Covid-19 Response Coordinator are being asked to re-evaluate the federal government’s Covid-19 data collection systems and report on their findings. It also calls on the heads of “all executive departments and agencies” to collect and share coronavirus-related data.

The Biden Administration

Updated

Jan. 22, 2021, 1:25 p.m. ET

The Trump administration struggled to agree on a centralized system last year, competing programs from the Department of Health and Human Services and the CDC. Alex M. Azar II, the former secretary for health and personnel services, ordered hospitals to send daily reports of virus cases to a private provider, who submitted them to a centralized database in Washington instead of the CDC, which held the data previously were stored. The decision, which remains in effect, disgruntled CDC scientists.

Another mandate is to set up a Covid-19 Task Force for “Health Justice”, which recommends providing more funds for parts of the population that are particularly hard hit by the virus and, among other things, the needs of race, ethnicity, Analyze geography and disability. Mr Biden said Thursday that the task force would address hesitation in taking the vaccines.

The panel, which is housed in the Department of Health and Human Services, is part of a larger effort by the Biden government to draw more attention to persistent racial and ethnic differences in access to health care as minorities have been hospitalized and involved in Covid-19 died much higher rates. Mr. Biden appointed Dr. Marcella Nunez-Smith, an Associate Professor of Internal Medicine, Public Health, and Management at Yale, to lead the task force.

Mr Biden issued an order to protect workers’ health during the pandemic and asked the occupational safety and health authority to publish new guidance for employers. The regulation also calls on the agency to step up enforcement of existing regulations to stop the spread of Covid-19 in the workplace.

The president also directed education, health and human services departments to issue new guidelines for safely reopening schools – a major controversy during the summer when White House and Health Department officials pressured the CDC to reduce the risk of posting Downplaying students back.

The Biden government is calling on the Secretary of Health and Human Services and the Director of the National Institutes of Health to work out a plan to support large, randomized trials of new drugs for Covid-19 and future public health crises . According to the Executive Order, the treatments should be “easy to manufacture, sell and administer, both domestically and internationally”.

The focus on randomized trials is on two emergency approvals – for convalescent plasma and the malaria drug hydroxychloroquine – that the Food and Drug Administration signed last year. Federal health officials, including FDA scientists, remain angry about the agency’s decisions under pressure from the Trump administration to clarify treatments without strong evidence from randomized trials.

Categories
Business

The New Yorker Journal Union Workers Stage Daylong Walkout

The New Yorker Magazine Union Employees Stage Daylong Walkout

The New Yorker’s union employees didn’t go to work Thursday.

The New York Union’s 100+ employees, which include fact checkers, web producers and a few other editorial staff, opted for the full-day strike after recent rounds of negotiations with management failed, said Natalie Meade, chairwoman of the union.

The problem is the payment. Ms. Meade, a fact-checker for the magazine, said the union wants to raise the minimum wage to $ 65,000. In recent negotiations, The New Yorker executives failed to hit that number and instead offered pay hikes that they described as “offensive”.

“They already know they are underpaying us,” said Ms. Meade.

The union, which does not represent the authors of the New York employees, has been working on a collective agreement since 2018. The strike started at 6 a.m. on Thursday and was supposed to last 24 hours.

Before the negotiations, the union conducted a salary study based on data from Condé Nast, the magazine’s parent company. The survey found that union workers at The New Yorker had an average salary of $ 64,000 and that the company’s editorial assistants received an average salary of $ 42,000.

In a statement on Thursday, a New York spokesman said that salary proposals made during recent rounds of negotiations were “initial offers”.

“We hope that, contrary to measures like this, the union will negotiate in good faith and return a counter-proposal, as is customary in negotiations,” the statement said. “This way we can work productively together to get a final contract as quickly as possible.”

The New York spokesman also criticized the union’s wage study, adding, “We are committed to fair pay. We dispute certain conclusions of this study and are determined to reach a fair agreement. “

In September, Senator Elizabeth Warren, Democrat of Massachusetts, and Representative Alexandria Ocasio-Cortez, Democrat of New York, withdrew from the New York Festival’s keynote speaker slots in solidarity with union workers planning a digital picket line for print management for a “just cause” to be included in their agreement.

“Just Reason” is a provision often found in union contracts that sets a standard that employers must adhere to in order to discipline disciplinary or fire service workers. New York management eventually agreed to include it.

The New York Union is part of the NewsGuild of New York, which represents employees of the New York Times, Reuters, The Daily Beast, and other news outlets.

Categories
World News

Your Friday Briefing – The New York Instances

Your Friday Briefing - The New York Times

A day after he was sworn in, President Biden rushed to set up his administration and dismantle some of the Trump administration’s most controversial policies.

Mr Biden released a national pandemic response plan that included 10 executive orders to increase capacity for coronavirus testing, wear masks on federal properties, and expand production of Covid-19 consumables. However, experts say that vaccine production facilities are already full or almost full and that production capacity will not increase significantly until April. Others fear that the president’s plan for 100 million shots in 100 days is far too modest.

Masked faces in a crowd: Our interactive graphic shows in more detail who attended Mr Biden’s inauguration.

Climate policy: Pete Buttigieg, Mr. Biden’s nominee for Secretary of Transportation, promised to make climate change a priority in policy-making. Here’s how he could do that.

The already overburdened UK National Health Service has taken increasingly desperate measures in the face of rising coronavirus hospitalizations, including urging the military to move patients and equipment, suspend urgent operations at organ transplant centers, and reduce patient oxygen levels by saving congested tubes.

Although vaccinations continue rapidly, deaths are increasing. The UK has suffered more per capita deaths from the coronavirus in the past week than any other country, hospitals continue to fill and for the second time in a year overwhelmed health workers struggle to keep patients alive.

Warning signs of a winter swarm had been evident, but Prime Minister Boris Johnson repeatedly avoided acting quickly, defying government scholars’ calls for a lockdown and other measures for weeks or months.

Quote: “It just didn’t have to be like that,” said a London ambulance. “The first time you could say that it was inevitable. It just feels completely avoidable, and it’s a lot harder to take. “

Here are the latest updates and maps of the pandemic.

In other developments:

The Russian government is threatening Radio Free Europe / Radio Liberty with fines of several million dollars and possible criminal charges. The news organization’s editors fear that for the first time since the collapse of the Soviet Union they will be forced to shut down in the country.

Given the growing public discontent in Russia, generally available non-Kremlin content has become a problem for President Vladimir Putin. For example, the outlet has invested in reporting on the anti-government protests in neighboring Belarus.

Context: The escalation of the government’s pressure campaign against the news agency shows how Putin is stepping up his stance in his conflict with Washington just as President Biden takes office.

Details: According to RFE / RL, the Russian government has reported dozens of violations of new requirements in the past few weeks, according to which all content has been flagged as created by a “foreign agent”. The editors say this would detract from the outlet’s credibility.

Robert Thomas Bigelow, a Las Vegas outsider, real estate and aviation mogul with billionaire appeal, offers nearly $ 1 million in prizes for the best evidence of “survival of consciousness after permanent body death.”

In other words, did Hamlet have the right to call death the inescapable frontier, “the undiscovered land from whose homeland no traveler returns”? Or does consciousness survive physical death in some form – as the Dalai Lama called it, as we just “change our clothes”?

Brexi; Britain apparently refuses to grant the ambassador of the European Union the same diplomatic status as other ambassadors because it is an international federation and not a nation-state.

Iraq bomb attack: Two suicide bombers detonated explosive vests in a crowded market in central Baghdad Thursday morning, killing at least 32 people in the largest such attack in years.

Canadian politics: Julia Payette, who represented Queen Elizabeth II, who represented Canada’s governor general and official head of state, a high-profile but largely ceremonial role, resigned Thursday after a report sharply criticized her treatment of staff.

Australia detention: Dozens of refugees and asylum seekers have been detained in Melbourne hotels for more than a year, often spending only an hour a day outside their rooms. Many seemed shocked when they were finally released this week.

Snapshot: Police found more than 800 cannabis plants in a basement near the Bank of England after reports of a strong smell in London’s financial district, which is largely empty due to lockdown restrictions. Above is the once flourishing company.

Art Basel: The international art trade’s hopes for a return to normal were thrown back when the organizers of the flagship fair planned for June in Switzerland announced that it would be postponed to September.

What we read: Many in the UK have found this recent lockdown to be particularly damaging to their mental health. This thoughtful article by the New Statesman explores why and what can be done about it.

Cook: Harissa is added to this Bolognese and made in a frying pan from start to finish – including the pasta that cooks right in the sauce.

Clock: The final season of “Call My Agent!” is now available on Netflix. Expect observational wit, physical slapstick, and satire alongside fits of thoroughly Gallic farce.

To plan: Consider a more mindful approach to post-pandemic travel – perhaps a personal challenge to master, explore your heritage, or achieve a goal in life.

Protect yourself and keep yourself busy. At Home offers a comprehensive collection of ideas for what to read, cook, see, and do while staying at home.

President Biden inherits tricky technical questions, including how to curb powerful digital superstars, what to do with Chinese technology, and how to get more Americans online. Our OnTech newsletter offers an insight into the challenges and opportunities of technology policy.

Restrict technical forces: There have been investigations and lawsuits under the Trump administration into the power of Google, Facebook, Amazon, Apple and other technology companies. Tech giants can expect more of this under Mr. Biden and a Democrat-controlled Congress. The new government is expected to continue filing lawsuits against Google and Facebook.

Categories
Health

Eli Lilly Claims Drug Prevents Coronavirus An infection in Nursing Houses

Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes

An unusual experiment to prevent nursing home employees and residents from being infected with the coronavirus is successful, drug manufacturer Eli Lilly announced on Thursday.

A drug containing monoclonal antibodies – laboratory-bred virus fighters – prevented symptomatic infections in residents who have been exposed to the virus, even in the frail elderly, who are most vulnerable. This is based on preliminary results from a study conducted in collaboration with the National Institutes of Health.

The researchers found an 80 percent reduction in infections in residents who received the drug compared to those who received a placebo and a 60 percent reduction in staff, results that were very statistically meaningful, Eli Lilly said.

The data has not yet been reviewed or published by experts. The company expects to present the results at a future medical meeting and publish them in a peer-reviewed journal, but did not say when.

The study included 965 participants in nursing homes: 666 employees and 299 residents. (The company had hoped more residents would attend, but it proved difficult to enroll. Many had dementia and others were suspicious of intravenous medication.)

There were four deaths from Covid-19 among study participants. All of them were among those living in nursing homes who were given a placebo, not the drug.

The drug Bamlanivimab already has an emergency approval from the Food and Drug Administration, which enables Eli Lilly to make it available to symptomatic patients early in the course of their infection.

However, this study asked if the drug could stop infections before they started. It was an unusual experiment: medical staff rushed to nursing homes in trucks equipped with mobile laboratories as soon as a single infection was found there. Once the workers arrived, they set up temporary infusion centers to administer the drug.

The research ended that weekend with an emergency meeting of the Data Protection and Monitoring Committee, an independent group that oversees the incoming results. The data was strong and convincing enough to bring the placebos to a halt.

Covid19 vaccinations>

Answers to your vaccine questions

If I live in the US, when can I get the vaccine?

While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.

When can I get back to normal life after vaccination?

Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.

Do I still have to wear a mask after the vaccination?

Yeah, but not forever. The two vaccines that may be approved this month clearly protect people from contracting Covid-19. However, the clinical trials that produced these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected with the coronavirus can spread it without experiencing a cough or other symptoms. Researchers will study this question intensively when the vaccines are introduced. In the meantime, self-vaccinated people need to think of themselves as potential spreaders.

Will it hurt What are the side effects?

The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection is no different from the ones you received before. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. However, some of them have experienced short-lived symptoms, including pain and flu-like symptoms that usually last a day. It is possible that people will have to plan to take a day off or go to school after the second shot. While these experiences are not pleasant, they are a good sign: they are the result of your own immune system’s encounter with the vaccine and a strong response that ensures lasting immunity.

Will mRNA vaccines change my genes?

No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given point in time, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

“When I saw the results table, my jaw dropped,” said Dr. Myron Cohen, professor of medicine at the University of North Carolina at Chapel Hill and principal researcher who helped design and conduct the study.

Although the study has ended, Dr. Daniel Skovronsky, Eli Lilly’s chief scientist, said the company would continue to rush to nursing homes on its study network if an outbreak is detected. “Everyone will get the drug,” he said.

Experts who did not take part in the study were delighted, but emphasized that they had not yet seen complete data. “I only see positive results here,” said Dr. Ofer Levy, director of the Precision Vaccination Program at Boston Children’s Hospital. “That’s a win.”

Dr. Kathleen Neuzil, director of the Center for Vaccine Development and Global Health at the University of Maryland Medical School, was also encouraged.

“The mortality effect is remarkable,” she said, adding that the drug should be used more widely to prevent and treat Covid-19, “especially in populations such as nursing home residents who have high mortality rates and may not respond optimally to vaccines . ” ”

Vaccines also protect people from contracting the virus, of course, and nursing home staff and residents were among the first group to be prioritized for the shots. But supplies are inadequate, and many nursing home workers who fear the vaccines have refused to get them.

And after vaccination, it can take six weeks for the body to produce enough antibodies for maximum protection, said Dr. Srilatha Edupuganti, vaccine researcher at Emory University in Atlanta and study researcher.

Treatment with monoclonal antibodies could provide almost equivalent protection immediately, although it does not last as long as the protection offered by a vaccine.

Eli Lilly plans to reach out to the FDA for an emergency clearance to use the drug to help prevent infection in frail elderly populations, especially in nursing homes or long-term care facilities, said Dr. Skovronsky.

Categories
Business

Hershey sees enterprise alternative in household film nights, tight budgets

Hershey sees business opportunity in family movie nights, tight budgets

Hershey saw a strange pattern emerge in early spring. Sales of Hershey’s milk chocolate six-packs soared online and in stores well before Memorial Day, the typical prelude to summer camping trips and backyard gatherings.

The S’more season started early and lasted for months, said Kristen Riggs, chief growth officer, Thursday at a virtual conference hosted by the National Retail Federation.

“It’s been the biggest S’Mores season we’ve ever had,” she said.

Families made the goodies in the back yard to break up the monotony during the pandemic. In parts of the country with higher Covid-19 rates, Hershey saw sales of these milk chocolate packs increase by 40% to 50% compared to other regions.

The S’Mores surge is an example of the growth opportunity the snack and confectionery company sees as consumers spend more time at home trying to create occasion during the global health crisis. Riggs said it wants to participate in new traditions like family movie nights, suggest recipes of candy, and serve customers who want a tasty but affordable treat.

She said the company is moving faster to identify and respond to changes in consumer behavior. When it discovered the s’more trend, she said it had ramped up milk chocolate bar production and inventory in stores. Marketing has been adjusted to portray s’mores as the ideal treat for a more intimate gathering in the back yard rather than a large social event.

“By reading these consumer and retail signals quickly, we were able to seize the opportunity,” she said.

At the start of the pandemic, she said Hershey had been delivering boxes of all of its snacks to a focus group of customers. They were asked how they use the products when they spend more time at home – whether they are placed in candy bowls, added to a baking recipe, or used as a snack during the work day. These findings were used to inform the business strategy.

Hershey’s portfolio includes well-known confectionery brands, like Reese’s, Almond Joy, KitKat, Twizzlers and Bubble Yum as well as SkinnyPop and Pirate’s Booty. It’s one of the consumer goods companies that has noticed trends in staying at home. Net sales rose 4% in the third quarter of the fiscal year as customers indulged themselves with Halloween candy early. Sales of baked goods such as peanut butter, cocoa and French fries, as well as salty snacks, rose by double digits compared to the same period of the previous year.

However, the chocolate company has to adjust to new consumer behavior. Instead of rummaging the aisles of grocery stores, shoppers quickly get in and out of stores. They celebrate holidays differently, which could change the amount of candy they buy. And the rise of online grocery shopping could reduce the chances of a consumer discovering a new product, seeing a Christmas display, or tossing an impulse buy like a candy bar into their shopping cart.

Earlier this month, Bank of America upgraded Hershey’s stock to buy, raising its price target to $ 168, an increase of nearly 13% from its current trading price. The analysts said the company has strong momentum and could benefit from it in the coming months as the introduction of vaccines improves sales outside of home and in emerging markets.

The company’s shares are down nearly 3% over the past year. The market capitalization is $ 31 billion.

Riggs said in an interview that the company is getting smarter when it comes to online product placement. She said it could place an ad for chocolate syrup near the ice cream range on a retailer’s app or website – something that is harder to do in the grocery store. In the digital world, this could lead to shopping during the holiday season by placing ads for sweets or baked goods near goods such as Christmas decorations. It can enable a customer to purchase a collection of recipe ingredients with one click.

It also used to put Christmas candy on shelves and websites, which it does again for Valentine’s Day as people see the seasons as a distraction.

“There is something special about these seasonal traditions and occasions that makes the apartment feel better,” she said.

If Halloween and Christmas are a guide, expect plenty of candy bowls for Valentine’s Day and extended celebrations.

Categories
Business

U.S. Vaccine Provide: What to Know

U.S. Vaccine Supply: What to Know

The demand for vaccines is growing rapidly as the US grapples with a record death rate from Covid-19 and the threat of new, more contagious variants. After a slow start in December, many states and cities have rapidly accelerated vaccine delivery, expanded access to larger populations, and established mass testing sites.

But now there’s a new wrinkle: some mayors and governors say they have run out of vaccines available and have had to cancel appointments.

The Biden government has promised to revise the country’s volatile vaccination efforts, but there is only so much it can do to increase the supply available.

Here’s what you need to know.

There are simply not enough doses of approved vaccines to meet the huge demand. And that probably won’t change in the next few months.

The two approved vaccine companies, Moderna and Pfizer, each have promised to make 100 million doses of vaccine available to the United States by the end of March, or enough to give 100 million people the two needed vaccinations.

But that doesn’t mean that those 200 million cans are lying in a factory warehouse somewhere waiting to be shipped. Both companies produce the cans at full capacity and jointly dispense between 12 and 18 million cans per week.

As of Wednesday, nearly 36 million doses of the Pfizer and Moderna vaccines had been distributed to state and local governments. However, only about 16.5 million shots were given to patients.

However, if the local health authorities are better able to handle the distribution of vaccines, they will ultimately catch up with the limited supply. Some local officials, including those in New York City, said they had already reached this point and canceled appointments because they said they didn’t have enough.

Vaccine experts and the companies themselves have stated that applying the Defense Production Act will not add much to supply, at least in the short term, although any little bit could help. This is because production facilities are already full or almost full and there is a global race to develop vaccines that use a limited amount of resources.

Despite criticism of the Trump administration for not using the Defense Production Act more aggressively to stimulate production of test supplies and protective equipment, it used the act many times to give vaccine manufacturers priority access to suppliers of raw materials and equipment.

In a plan released Thursday, the Biden government announced that it would continue to use the law to increase supplies needed to make vaccines, as well as other materials needed to immunize tens of millions of people. Although the plan was few in detail, one example cited is to increase production of a special syringe that can squeeze six doses out of Pfizer vials that were originally supposed to contain five.

There are no vaccine reserves to speak of. For the most part, vaccines are shipped every week when they are made. (The exception is a small emergency supply that the Biden government has announced will continue.)

Last week, Alex M. Azar II, the outgoing Secretary for Health and Human Services, caused confusion when he announced that the federal government would release a reserve of vaccine doses. Many states have been told that an influx of vaccines is on the way that will allow more people to be vaccinated.

In his press conference, Mr Azar urged states to open their vaccination guidelines, saying they moved too slowly to use the doses they had already received. As a result, several governors, including Andrew M. Cuomo of New York, changed admissions rules to allow people 65 and older to have the vaccine.

However, last Friday, senior administration officials made it clear that all of those reserve doses were already earmarked as booster shots for people who had received the vaccine, and that Mr Azar was just setting out the logical extension of a distribution policy established by federal officials in December when supplies began. The release of the reserve doses would go to people who needed their second dose, not new groups of people who received their first shot.

In the future, Azar said, the government will switch to a new model: instead of sticking to a reserve of booster shots, every weekly shipment from the manufacturers would include doses for new people as well as second doses for those due for their booster shots. President Biden repeated this policy when he announced his vaccination schedule last week.

The Biden Administration

Updated

Jan. 21, 2021, 8:45 p.m. ET

Federal officials previously said they worked with states to find out who received a vaccine and when they were due for their booster shots, three weeks later for the Pfizer vaccine, and four weeks later for the Moderna vaccine.

They said that each weekly delivery gives priority to people who need their second dose that week, and what is left is used to vaccinate new people.

However, the plan relies on federal and state governments working together to specify exactly who has received a vaccine and what is needed from week to week. Many state governments have complained that they do not have the resources to carry out the vaccine distribution plan and the next few weeks will show how well the system works.

Biden’s new administration has vowed to revise the distribution to the states to give local officials more transparency on how much vaccine to expect in hopes of allowing states to better plan.

No, that probably won’t happen.

Last week, Michigan Governor Gretchen Whitmer asked the federal government for permission to buy 100,000 doses of vaccine directly from Pfizer. And on Monday, Mr. Cuomo wrote a letter to Pfizer asking the state to buy vaccines direct.

Pfizer and Moderna supplies have been fully drawn for at least the first quarter of this year, meaning a replacement vaccine is unlikely to be sold to individual states.

Additionally, the emergency approvals for the Pfizer and Moderna vaccines provide for the federal government to oversee distribution.

In a statement, a Pfizer spokeswoman said the company is “open to working with the US Department of Health on a distribution model that will allow as many Americans as possible to get access to our vaccine as soon as possible.” However, she noted that “before we can even think about direct sales to state governments, HHS would have to approve the proposal.”

A state official said Tuesday that the governor felt it was important to exhaust all of his options, no matter how unlikely they might be, and pointed to his efforts in March to buy fans direct from manufacturers – which sparked a bidding war between states he later criticized the federal government for refueling.

However, advisors to the Biden government have indicated that they are not in favor of such a move. On Monday, Dr. Celine Gounder, a pandemic advisor to Mr Biden during his change of presidency, said that if states could do separate deals, it would cause more problems than it would solve.

In an interview on CNBC, Dr. Gounder’s earlier criticism from Mr. Cuomo for bidding on ventilators. “I think this kind of approach to vaccine allocation will frankly lead to the same situation that he himself criticized last spring,” she said.

Yes, most likely.

At least three other vaccines are in late-stage clinical trials, and the success of any of those vaccines could mean millions more doses for US citizens by spring.

Johnson & Johnson is expected to announce the results of its vaccine study every day. If this is successful, the first doses could be available in the US by February. Although early production of the vaccine has lagged, the company has signed a contract to deliver 100 million doses of its single-dose vaccine by the end of June.

Results of studies with two-dose vaccines from AstraZeneca and Novavax could also be published by March and April. AstraZeneca has an agreement with the US government to supply 300 million doses and Novavax to supply 110 million doses.

Additionally, both Pfizer and Moderna state that their factories are adding and expanding capacity every week. They have signed contracts to deliver an additional 100 million doses of their vaccines each during the second quarter of this year.

It’s still not clear, though conservative, that there could be enough vaccines by the summer.

With no other vaccines approved, the United States has signed contracts with Pfizer and Moderna for a total of 400 million doses to be dispensed by the summer, or enough for 200 million people.

That’s pretty close to the American population of 260 million adults (the vaccines aren’t yet approved for children, although studies are ongoing).

But if other vaccines prove safe and effective – which experts believe is likely – millions of people could be vaccinated faster, possibly by late spring.

Categories
Health

J&J plans to have 100 million vaccines for Individuals by spring, board member says

J&J plans to have 100 million vaccines for Americans by spring, board member says

Dr. Johnson & Johnson board member Mark McClellan told CNBC that “if the clinical trial works,” the company could significantly increase the availability of Covid vaccines in the coming weeks.

“I know J&J has a very large supply with its production both here in the US and elsewhere in the world, with the goal of maybe having enough vaccines for 100 million Americans by spring or April So,” said the former FDA commissioner in a Thursday evening interview on “The News with Shepard Smith”.

During a speech at the White House Thursday, government lead infectious disease doctor Anthony Fauci said Johnson & Johnson would have enough data on its vaccine to start analysis within a week or two. McClellan told host Shepard Smith that the most important thing about the company’s vaccine is the large-scale clinical trial that is ongoing.

“Based on these results, the independent scientists overseeing this study should take a closer look in the near future and we’ll see how quickly the vaccine could advance,” McClellan said.

According to the Centers for Disease Control and Prevention, an average of 883,000 syringes of the Covid vaccine are given per day in the US for the past six days. Even so, less than 50% of the 37,960,000 cans distributed have found their way into people’s arms.

At least 12 states have reported vaccine shortages. Officials from San Francisco and New York warned they could be completely out of dose this week. At least 15 vaccination sites in New York City are temporarily closed. New York Mayor Bill DeBlasio told NBC’s Gabe Gutierrez that at least 23,000 vaccine appointments must be postponed.

McClellan noted that “the supply will go up, but probably not enough to keep up with the large number of Americans who are now really looking to get vaccinated.” However, he told Smith that he believes the Biden administration can help speed up the vaccine adoption rate.

“It’s going to be a challenge, but I think more than 100 million Americans can be vaccinated in the next few months,” said McClellan, a health policy expert at Duke University.

President Joe Biden promised a “full war effort” to fight the coronavirus pandemic and accelerate vaccine production using the Defense Production Act during a briefing Thursday.

“We have already identified suppliers and are working with them to move the plan forward,” said Biden.

He added that the DPA would help fix supply chain issues, including a shortage of syringes.